 |
|
Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
Yousef Nassar, Seth Richter
J Bone Metab. 2018;25(3):141-151. Published online 2018 Aug 31 DOI: https://doi.org/10.11005/jbm.2018.25.3.141
|
|
Citations to this article as recorded by
 Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study
Takuma Murofushi, Tatsuya Yagi, Daiki Tsuji, Daisuke Furushima, Tomoyuki Fujikura, Kunihiko Itoh, Junichi Kawakami
Naunyn-Schmiedeberg's Archives of Pharmacology.2024;[Epub] CrossRef Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed
Journal of Health Economics and Outcomes Research.2024;[Epub] CrossRef Budget Impact of RefluxStopTM as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed
Journal of Health Economics and Outcomes Research.2024; : 1. CrossRef Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
Shintaro Hayashi, Tomohito Moriyama, Yuichiro Ito, Yuta Harada, Hiroki Dodo, Kana Kumahara, Tatsuji Yogi, Noritsugu Ohashi, Reiji Higashi, Akihiro Mori
Japanese Journal of Infectious Diseases.2024;[Epub] CrossRef Osseous implications of proton pump inhibitor therapy: An umbrella review
Abdullah S. Alanazi, Hadiah Almutairi, Jeetendra Kumar Gupta, Dibyalochan Mohanty, Deepankar Rath, Ali A. AlOdan, Ahmed Mahal, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin, Sarvesh Rustagi, Prakasini Satapathy, Hashem Abu Serhan
Bone Reports.2024; 20: 101741. CrossRef Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database
Kosuke Suzuki, Ayako Watanabe, Yoshihiro Kiryu, Eisuke Inoue, Kenji Momo
Biological and Pharmaceutical Bulletin.2024; 47(2): 518. CrossRef PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the Fracture Liaison Service
M.R. Schene, M.S.A.M. Bevers, W.J.F. van der Vijgh, J.H.M. Driessen, L. Vranken, R.Y. van der Velde, H.C. Willems, C.E. Wyers, J.P. van den Bergh
Bone.2024; 182: 117066. CrossRef Proton pump inhibitors, bone and phosphocalcic metabolism
Cécile Philippoteaux, Julien Paccou, Emmanuel Chazard, Bernard Cortet
Joint Bone Spine.2024; 91(5): 105714. CrossRef Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Liz Gemmill, Paul J. Goldsmith, Ahmed R. Ahmed
Journal of Medical Economics.2023; 26(1): 603. CrossRef Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis
Arup Choudhury, Anuraag Jena, Vaneet Jearth, Amit K Dutta, Govind Makharia, Usha Dutta, Mahesh Goenka, Rakesh Kochhar, Vishal Sharma
Expert Review of Gastroenterology & Hepatology.2023; 17(5): 479. CrossRef The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study
Donal Fitzpatrick, Rosaleen Lannon, Eamon Laird, Mary Ward, Leane Hoey, Catherine F. Hughes, J. J. Strain, Conal Cunningham, Helene McNulty, Anne M. Molloy, Kevin McCarroll
Osteoporosis International.2023; 34(11): 1917. CrossRef Pantoprazole-Induced Bone Loss through Gastrin Secretion: A Stereological Study
Forough Saki, Mesbah Shams, Sanaz Dastghaib, Farhad Koohpeyma, Sushil K. Jha
BioMed Research International.2023; 2023: 1. CrossRef Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength
Md. Saddam Hussain, Tanoy Mazumder
Journal of Basic and Clinical Physiology and Pharmacology.2022; 33(5): 567. CrossRef Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trials
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth M Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, Athira Balakrishnan Nair, Paul T. Antony, Alexander C. Ford, Nathorn Chaiyakunapruk
British Journal of Clinical Pharmacology.2022; 88(4): 1551. CrossRef Current options and investigational drugs for the treatment of eosinophilic esophagitis
Sonsoles Tamarit-Sebastian, Francisco Miguel Ferrer-Soler, Alfredo J Lucendo
Expert Opinion on Investigational Drugs.2022; 31(2): 193. CrossRef The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)
Ahmed Al-Marhabi, Ahmed Hashem, Bader Faiyaz Zuberi, Charles Onyekwere, Imran Lodhi, Mohamed Mounir, Saad Alkhowaiter, Sameer Al Awadhi, Vasudevan G. Naidoo, Yasser Hamada
Expert Review of Gastroenterology & Hepatology.2022; 16(3): 217. CrossRef The Association between Helicobacter pylori Seropositivity and Bone Mineral Density in Adults
Jinke Huang, Zhihong Liu, Jinxin Ma, Jiali Liu, Mi Lv, Fengyun Wang, Xudong Tang, Hongmei Jiang
Mediators of Inflammation.2022; 2022: 1. CrossRef Drug treatment strategies for eosinophilic esophagitis in adults
Alfredo J Lucendo
Expert Opinion on Pharmacotherapy.2022; 23(7): 827. CrossRef Outcomes associated with proton pump inhibitors and distal radius fractures: A post-hoc comparative analysis
Kevin M. Klifto, David S. Ruch, Suhail K. Mithani, Tyler S. Pidgeon, Marc J. Richard, Christopher S. Klifto
Journal of Plastic, Reconstructive & Aesthetic Surgery.2022; 75(8): 2650. CrossRef A comparison of survival models for prediction of eight-year revision risk following total knee and hip arthroplasty
Alana R. Cuthbert, Lynne C. Giles, Gary Glonek, Lisa M. Kalisch Ellett, Nicole L. Pratt
BMC Medical Research Methodology.2022;[Epub] CrossRef Rebuilding trust in proton pump inhibitor therapy
Alla Turshudzhyan, Sonia Samuel, Angela Tawfik, Micheal Tadros
World Journal of Gastroenterology.2022; 28(24): 2667. CrossRef Proton Pump Inhibitors and Bone Health: An Update Narrative Review
Eric Lespessailles, Hechmi Toumi
International Journal of Molecular Sciences.2022; 23(18): 10733. CrossRef Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis
Thuila Ferreira da Maia, Bruna Gafo de Camargo, Meire Ellen Pereira, Cláudia Sirlene de Oliveira, Izonete Cristina Guiloski
International Journal of Environmental Research and Public Health.2022; 19(20): 13501. CrossRef Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications
Johanna C Meyer, Sean MacBride-Stewart , Joseph O Fadare, Ammar Abdulrahman Jairoun, Mainul Haque, Amos Massele, Santosh Kumar, Israel Abebrese Sefah, Phumzile P Skosana , Brian Godman
Cureus.2022;[Epub] CrossRef The therapeutic importance of acid-base balance
Bianca N. Quade, Mark D. Parker, Rossana Occhipinti
Biochemical Pharmacology.2021; 183: 114278. CrossRef Actualización en la prescripción de inhibidores de la bomba de protones. Qué hacer y qué no hacer
G.M. Saiz Ladera, M.E. Pejenaute Labari, J.N. García Pascual
Medicina de Familia. SEMERGEN.2021; 47(4): 267. CrossRef Different elemental infant formulas show equivalent phosphorus and calcium bioavailability in healthy volunteers
Clemens Bergwitz, Simone R.B.M. Eussen, Pilou L.H.R. Janssens, Monique Visser, Thomas O. Carpenter, Ardy van Helvoort
Nutrition Research.2021; 85: 71. CrossRef Herbal medicines in functional dyspepsia—Untapped opportunities not without risks
Kok‐Ann Gwee, Gerald Holtmann, Jan Tack, Hidekazu Suzuki, Jinsong Liu, Yinglian Xiao, Min‐Hu Chen, Xiaohua Hou, Deng‐Chyang Wu, Clarissa Toh, Fang Lu, Xu‐Dong Tang
Neurogastroenterology & Motility.2021;[Epub] CrossRef Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature
Silvia Irina Briganti, Anda Mihaela Naciu, Gaia Tabacco, Roberto Cesareo, Nicola Napoli, Pierpaolo Trimboli, Marco Castellana, Silvia Manfrini, Andrea Palermo, Arturo Bevilacqua
International Journal of Endocrinology.2021; 2021: 1. CrossRef Low-dose PPI to prevent bleeding after ESD: A multicenter randomized controlled study
Li Yang, Jian Qi, Weiqing Chen, Qinghong Guo, Rui Xie, Zhifeng Zhao, Shanyu Qin, Aiming Liu, Mingming Den, Chaoqiang Fan, Jianyin Bai, Hui Lin, Hong Guo, Shiming Yang
Biomedicine & Pharmacotherapy.2021; 136: 111251. CrossRef Comment on: Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement
Michel Gagner
Surgery for Obesity and Related Diseases.2021; 17(6): 1229. CrossRef Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis
Alex H. Gifford, Julie L. Sanville, Meghana Sathe, Sonya L. Heltshe, Christopher H. Goss
Pediatric Pulmonology.2021; 56(7): 2048. CrossRef Phosphorus bioaccessibility measured in four amino acid–based formulas using in-vitro batch digestion translates well into phosphorus bioavailability in mice
Sampada Chande, Francina Dijk, Jonathan Fetene, Steven Yannicelli, Thomas O. Carpenter, Ardy van Helvoort, Clemens Bergwitz
Nutrition.2021; 89: 111291. CrossRef Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors
Elizabeth M. Salvo, Nicole C. Ferko, Sarah B. Cash, Ailish Gonzalez, Peter J. Kahrilas
Alimentary Pharmacology & Therapeutics.2021; 54(2): 129. CrossRef Effect of Omeprazole on Osteoblasts and Osteoclasts in vivo and in the in vitro Model Using Fish Scales
Mohamed I. Zanaty, Adel Abdel-Moneim, Yoichiro Kitani, Toshio Sekiguchi, Nobuo Suzuki
Biochemistry (Moscow).2021; 86(10): 1192. CrossRef Влияние омепразола на остеобласты и остеокласты in vivo и в модели in vitro с использованием чешуи рыбы
M.I. Zanaty, A. Abdel-Moneim, Y. Kitani, T. Sekiguchi, N. Suzuki
Биохимия.2021; 86(10): 1423. CrossRef Proton‐Pump Inhibitors
Marta Tavares, Jorge Amil‐Dias
Journal of Pediatric Gastroenterology and Nutrition.2021; 73(6): 665. CrossRef Proton Pompa İnhibitörlerinin Kırık Oluşumuna Etkisi ve Bakıma Yansıması
Seda AKUTAY, Özlem CEYHAN
Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi.2021; 14(1): 62. CrossRef Hospitalized fracture rates amongst patients with chronic kidney disease in Australia using data linkage
Raymond Lin, Nigel D. Toussaint, Martin Gallagher, Alan Cass, Sradha Kotwal
Nephrology.2020; 25(6): 475. CrossRef Targeted Therapies for Eosinophilic Gastrointestinal Disorders
Alfredo J. Lucendo, Piedad López-Sánchez
BioDrugs.2020; 34(4): 477. CrossRef Effects of Calcium and Annatto Tocotrienol Supplementation on Bone Loss Induced by Pantoprazole in Male Rats Kok-Yong Chin, Benjamin Ka Seng Thong, Rhivaldy Faahim Kamalulloh, Nur Vaizura Mohamad, Sok Kuan Wong, Azlan Mohd Arlamsyah, Rahma Triliana, Ima Nirwana Soelaiman
Drug Design, Development and Therapy.2020; Volume 14: 2561. CrossRef Potential proton pump inhibitor–related adverse effects
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega
Annals of the New York Academy of Sciences.2020; 1481(1): 43. CrossRef The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors
Nathan Fleishman, Troy Richardson, Thomas Attard
Journal of Pediatric Gastroenterology and Nutrition.2020; 70(6): 815. CrossRef Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies
Alfredo J Lucendo
Expert Review of Clinical Immunology.2020; 16(1): 63. CrossRef Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target?
Yohannes T. Ghebre
Frontiers in Endocrinology.2020;[Epub] CrossRef Association between proton pump inhibitor use and risk of fracture: A population-based case-control study
Jong Joo Kim, Eun Jin Jang, Jiwon Park, Hyun Soon Sohn, Robert Daniel Blank
PLOS ONE.2020; 15(7): e0235163. CrossRef Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies
Hee-Eun Hong, A-Sol Kim, Mi-Rae Kim, Hae-Jin Ko, Min Kyu Jung
Cancers.2020; 12(8): 2220. CrossRef Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay
Enrica Di Martino, Alessio Provenzani, Piera Polidori, Vincenzo De Luca
PLOS ONE.2020; 15(8): e0238064. CrossRef Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
Leon Fisher, Alexander Fisher, Paul N Smith
Journal of Clinical Medicine.2020; 9(10): 3253. CrossRef Effect of proton pump inhibitors on bone mineral density: A systematic review and meta-analysis of observational studies
Sara Aleraij, Sultan Alhowti, Mazen Ferwana, Imad Abdulmajeed, Ibrahim Mohsen Mutawwam
Bone Reports.2020; 13: 100732. CrossRef Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour
Current Diabetes Reviews.2020; 16(9): 984. CrossRef Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis
Jian Liu, Xianqing Li, Lei Fan, Jie Yang, Jiecong Wang, Jiaming Sun, Zhenxing Wang
Life Sciences.2019; 218: 213. CrossRef Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?
Toshihiro Sugiyama
American Journal of Gastroenterology.2019; 114(2): 360. CrossRef Association of Proton Pump Inhibitor Use and Risk of Fracture Based on the National Health Insurance Sample Cohort Database (2002~2013)
Jong Joo Kim, Eun Jin Jang, Junwoo Cho, Hyun Soon Sohn
Korean Journal of Clinical Pharmacy.2019; 29(3): 147. CrossRef Association between Peptic Ulcer Disease and Osteoporosis: The Population-Based Longitudinal Cohort Study in Korea
Phill Hoon Yoon, Sang Joon An, Seok-Hoo Jeong, Yun-Jung Yang, Yeon-pyo Hong
International Journal of Environmental Research and Public Health.2019; 16(15): 2777. CrossRef
|